Patent US4509700A successfully refreshed from Google Patents.
Patent US5023248A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5023248A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of treating diabetes with inositol triphosphate

Assignee: Perstorp AB
•
Filing: 1988-09-30
•
Granted: 1991-06-11
•
Expires: 2008-09-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of treating diabetes or complications of diabetes is disclosed. In this method a pharmaceutically effective amount of at least one isomer of inositol triphosphate is administered to a human or an animal in need thereof.

Inventors

  • 👤 Matti Siren

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 16:35
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A21; A21D; A21D2/00; A21D2/08; A21D2/30; A23; A23B; A23B2/00; A23B2/70; A23B2/725; A23B2/729; A23B2/775; A23B7/00; A23B7/14; A23B7/153; A23B7/154; A23L; A23L29/00; A23L29/03; A23L29/05; A61K31/00; A61K31/66; A61K33/00; A61K33/04; A61K47/00; A61K47/06; A61K47/24; C; C07; C07F; C07F9/00; C07F9/02; C07F9/06; C07F9/08; C07F9/09; C07F9/117; C12; C12P; C12P9/00

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 38 words
A method of treating diabetes or complications of diabetes in a human or an animal comprising administering to a human or an animal in need thereof a pharmaceutically effective amount of at least oneisomer of an inositol triphosphate.
Claim 2
Independent Claim 38 words
A method of treating diabetes or complications of diabetes in a human or an animal comprising administering to a human or an animal in need thereof a pharmaceutically effective amount of at least oneisomer of an inositol triphosphate.
Claim 3
Dependent Claim 20 words
A method according to claim 1, wherein said diabetic complication is diabetic retinopathy, diabetic neurophaty, diabetic nephorpathy or diabetic microangiopathy.
Claim 4
Dependent Claim 20 words
A method according to claim 1, wherein said diabetic complication is cataract formation, changes in lipid methabolism, hyperglycemia or hyperketonemia.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-06-10 1994-12-10 1995-06-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-06-10 1998-12-10 1999-06-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-06-10 2002-12-10 2003-06-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag